b3c newswire is the leading PR distribution service for biotech press releases. With more than 1,500 media titles worldwide we have the largest reach in biotech and pharmaceutical trade media currently available. Due to our “specialized channels” an excellent visibility of your news is assured.

Your benefits
> More visibility:
Unparalleled reach in U.S., EU and Asia/Pacific
> Safes time:
No need to maintain own media lists. b3c newswire is available on a fee-for-service basis.
> Up-to-date media contacts:
We continuously update and extend our media database.
> Cost-effective service:
Unlike our competitors, we have a flatrate for global distribution and don’t charge every geographic circuit separately.
> Ideal supplementation to financial news distribution:
b3c newswire can be used stand-alone or in combination with financial distribution.